~ Revenue Growth and Margin Expansion Highlight a Strong Start to the Year ~
IRVINE, Calif., February 18, 2025--(BUSINESS WIRE)--Mobix Labs, Inc. (Nasdaq: MOBX) ("Mobix Labs" or the "Company"), a leading provider of advanced connectivity solutions, today announced financial results for the first quarter of fiscal 2025, which ended December 31, 2024.
"We are pleased with our strong start to fiscal 2025, demonstrating continued revenue growth," said Fabian Battaglia, CEO of Mobix Labs. "Our strategic acquisitions and expanding product portfolio continue to drive demand across key sectors, positioning us well for sustained growth."
Battaglia further commented "our revenue growth increased 11-fold compared to the same fiscal quarter last year, underscoring our exceptional growth trajectory. Along with our fourth consecutive quarter of reduced operating losses. We remain focused on driving financial discipline while pursuing strategic opportunities to enhance shareholder value."
Financial Highlights for First Quarter 2025
Revenue: $3.17 million, exceeding guidance provided in prior earnings call;
Adjusted Gross Margin: $54.1%
Adjusted Loss from Operations: $2.5 million, an improvement of 28.9% from the prior fiscal quarter.
Strengthened relationships with key aerospace and defense customers through EMI and connectivity solutions.
Expanded research collaborations in next-generation connectivity and multi-spectral imaging applications.
Non-GAAP Financial Measures
In addition to reporting financial results in accordance with U.S. generally accepted accounting principles (GAAP), the Company uses certain non-GAAP measures of financial performance, including:
Adjusted Gross Profit, which is defined as GAAP Gross Profit excluding amortization of acquisition-related intangible assets, inventory write-offs and stock-based compensation expense; and
Adjusted Loss from Operations, which is defined as GAAP Loss from Operations excluding depreciation, amortization of acquisition-related intangible assets, merger and acquisition-related expenses, inventory write-offs and stock-based compensation expense.
The Company’s management believes it is useful to consider these non-GAAP financial measures, together with the corresponding GAAP financial measures, as they provide more transparency into current business trends, exclusive of the effects of certain non-cash expenses, acquisition-related charges, and items that may not be present in comparative fiscal periods. Management believes that, when considered together with reported GAAP financial measures, these non-GAAP financial measures are useful to investors and management in understanding the Company’s ongoing operations and operating trends and in analyzing the Company’s underlying financial performance.
These non-GAAP financial measures are not intended to be considered in isolation from, as a substitute for, or superior to, the comparable GAAP measures. These non-GAAP financial measures may be different from similarly titled measures used by other companies. In the future, Mobix may consider whether other items should also be excluded in calculating the non-GAAP financial measures it uses. Management believes that the presentation of these non-GAAP financial measures provides investors with additional useful information to measure Mobix Labs’ financial and operating performance. In particular, these measures facilitate comparison of our operating performance between periods and may help investors to understand better our operating results. Internally, management uses these non-GAAP financial measures in assessing the Company's operating results and in planning and forecasting. A reconciliation of these non-GAAP financial measures to the most comparable GAAP measure is contained in the financial tables to this press release.
Shortly after the completion of the conference call, an archived version of the webcast will be available on the Company’s investor relations website at investors.mobixlabs.com.
About Mobix Labs, Inc.
Mobix Labs designs, develops and sells components and systems for advanced wireless and wired connectivity, radio frequency ("RF"), switching and electromagnetic interference ("EMI") filtering technologies. Our solutions are used in the consumer commercial, industrial, automotive, medical, aerospace, defense and other markets. To enhance our product portfolio, we also intend to pursue acquisitions of companies with existing revenue which can be scaled, and which possess technologies that accelerate the speed, accessibility, and efficiency of disruptive or more efficient communications solutions, and which will also allow us to expand into strategically aligned industries. Our wireless systems solutions include products for advanced RF and millimeter wave ("mmWave") 5G communications, mmWave imaging, software defined radio and custom RF integrated circuits ("ICs") targeting the commercial, industrial, and defense and aerospace sectors. Our interconnect products, including EMI filter inserts and filtered and non-filtered connectors, are designed for and are currently used in aerospace, military, defense and medical applications.
Mobix Labs and the logo, are among the trademarks of Mobix Labs. Other trademarks are the property of their respective owners.
Forward-Looking Statements
This press release contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S.Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about (i) our expectations regarding customer demand and requests for proposals as well as our ability to expand our customer base andproduct offerings; (ii) our financial outlook, including expectations regarding revenue growth and adjusted loss from operations; (iii)our ability to secure additional financing and any strategic initiatives, specifically with respect to synergistic product acquisitions;(iv) our expectations regarding our intent to acquire Spacecraft and any other possible acquisitions and (v) the impact of anystrategic partnerships on our business, are forward-looking statements. Although Mobix Labs believes that the expectationsreflected in the forward-looking statements are reasonable, Mobix Labs cannot guarantee future results, levels of activity,performance, achievements, or events and circumstances reflected in the forward-looking statements will occur. Forward-looking statements involve inherent risks and uncertainties, and a number of factors could cause actual results to differ materially fromthose contained in any forward-looking statement. As a result of a number of known and unknown risks and uncertainties, theactual results or performance of Mobix Labs may be materially different from those expressed or implied by these forward-lookingstatements. Some factors that could cause actual results to differ include our ability to enter into a definitive agreement to acquire Spacecraft, as well as our ability to meet the closing conditions to acquire Spacecraft; the inability to meet future capitalrequirements and risks related to Mobix Labs’ ability to raise additional capital; the risk that Mobix Labs is unable to successfullycommercialize its products and solutions, or experience significant delays in doing so; the risk that Mobix Labs may not be able togenerate income from operations in the foreseeable future; the risks concerning Mobix Labs’ ability to continue as a goingconcern; the inability to maintain the listing of Mobix Labs’ securities on Nasdaq; the risk that the price of Mobix Labs’ securitiesmay be volatile due to a variety of factors, including changes in the highly competitive industries in which Mobix Labs operates,variations in performance across competitors, changes in laws, regulations, technologies, the global supply chain, and macro-economic and social environments affecting Mobix Labs’ business and changes in the combined capital structure; the risk thatMobix Labs experiences difficulties in managing its growth and expanding operations; the risk that Mobix Labs may not be able to consummate planned strategic acquisitions, or fully realize anticipated benefits from past or future acquisitions or investments; therisk that litigation may be commenced against Mobix Labs; the risk that Mobix Labs’ patent applications may not be approved ormay take longer than expected, and Mobix Labs may incur substantial costs in enforcing and protecting its intellectual property;Mobix Labs’ reliance on a limited number of customers and retaining those customers; the impact of health epidemics, such as theCOVID-19 pandemic, on Mobix Labs’ business and industry and the actions Mobix Labs may take in response thereto and toother geopolitical concerns; and in some cases, forward-looking statements can be identified by words or phrases such as "may,""will," "expect," "anticipate," "target," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or othersimilar expressions. The foregoing list of factors is not exhaustive. You should carefully consider the foregoing factors and theother risks and uncertainties described in the "Risk Factors" section of our Quarterly Report on Form 10-Q filed with the Securitiesand Exchange Commission ("SEC") on August 14, 2024, and in any subsequent filings with the SEC. All information provided inthis press release is as of the date of this press release, and Mobix Labs undertakes no duty to update such information, exceptas required under applicable law.
Mobix Labs, Inc.
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
(unaudited, in thousands, except share and per share amounts)
Three months ended December 31,
FY
2024
2023
Inc (Dec) $
%
Net revenue
$
3,169
$
285
$
2,884
1011.9
%
Cost of revenue
1,482
329
1,153
350.5
%
Gross profit
1,687
(44
)
1,731
nm
Research and development
611
1,562
(951
)
-60.9
%
Selling, general and administrative
15,706
15,663
43
0.3
%
Loss from operations
(14,630
)
(17,269
)
2,639
-15.3
%
Interest expense
211
857
(646
)
-75.4
%
Change in fair value of earnout liability
1,940
(24,764
)
26,704
-107.8
%
Change in fair value of warrants
2,658
60
2,598
nm
Change in fair value of PIPE make-whole liability
-
2,904
(2,904
)
-100.0
%
Merger-related transaction costs expensed
-
4,009
(4,009
)
-100.0
%
Other non-operating losses, net
402
10
392
nm
Loss before income taxes
(19,841
)
(345
)
(19,496
)
nm
Provision (benefit) for income taxes
(2
)
(1,280
)
1,278
-99.8
%
Net income (loss) and comprehensive income (loss)
$
(19,839
)
$
935
$
(20,774
)
nm
Net income (loss) per share of Class A and Class B Common Stock:
Basic
$
(0.52
)
$
0.04
Diluted
$
(0.52
)
$
0.04
Weighted-average common shares outstanding:
Basic
38,425,566
18,617,656
Diluted
38,425,566
23,316,071
Mobix Labs, Inc.
Reconciliation of Non-GAAP Financial Measures
(unaudited, in thousands)
Three months ended December 31,
2024
2023
Computation of Adjusted Loss from Operations:
GAAP loss from operations
$
(14,630
)
$
(17,269
)
Depreciation
123
113
Amortization of acquisition related intangible assets
471
237
Merger & acquisition- related expenses
1,646
117
Stock-based compensation expense
9,802
12,705
Adjusted loss from operations
$
(2,588
)
$
(4,097
)
Three months ended December 31,
2024
2023
Computation of Adjusted Gross Profit:
GAAP gross profit
$
1,687
$
(44
)
GAAP gross margin %
53.2
%
-15.4
%
Amortization of acquisition-related intangible assets
11
68
Stock-based compensation expense
16
-
Adjusted Gross Profit
$
1,715
$
24
Adjusted Gross Margin %
54.1
%
8.4
%
Mobix Labs, Inc.
Condensed Consolidated Balance Sheets
(unaudited, in thousands, except share and per share amounts)
December 31, 2024
September 30, 2024
ASSETS
Current assets
Cash
$
405
$
266
Accounts receivable, net
1,876
2,813
Inventory
1,242
1,725
Prepaid expenses and other current assets
301
467
Total current assets
3,824
5,271
Property and equipment, net
1,070
1,177
Intangible assets, net
14,740
15,211
Goodwill
16,066
16,066
Operating lease right-of-use assets
1,084
1,022
Other assets
487
341
Total assets
$
37,271
$
39,088
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Current liabilities
Accounts payable
$
10,944
$
10,833
Accrued expenses and other current liabilities
11,894
10,325
Deferred purchase consideration
2,272
2,380
Notes payable, current
723
398
Notes payable - related parties, current
2,023
1,743
Operating lease liabilities, current
583
428
Total current liabilities
28,439
26,107
Notes payable, noncurrent
71
200
Notes payable - related parties, noncurrent
802
1,082
Earnout liability
3,620
1,680
Deferred tax liability
315
320
Operating lease liabilities, noncurrent
901
1,024
Other noncurrent liabilities
6,162
3,145
Total liabilities
40,310
33,558
Stockholders' equity (deficit)
Common stock, $0.00001 par value
-
-
Additional paid-in capital
121,257
109,987
Accumulated deficit
(124,296
)
(104,457
)
Total stockholders' equity (deficit)
(3,039
)
5,530
Total liabilities and stockholders' equity (deficit)
